跳至主要内容
临床试验/CTRI/2023/11/060251
CTRI/2023/11/060251尚未招募Unknown

ocal application of specific Unani drug for medical management of Oral submucous fibrosis (OSF): A randomized controlled clinical trial

Dr Arvind Kumar Kairo0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age greater than or equal to 18 years , either gender.
  • 2. Treatment naive patients diagnosed with stage 1,2 and 3 OSF.
  • 3. Stage 1 OSF > 35 mm with other clinical features of OSF.
  • 4. Stage 2 OSF -26-35 mm
  • 5. Stage 3 OSF -15-26 mm
  • 6. Patients who will give consent and agree to continue follow up for 1 year.

排除标准

  • 1. Histopathological evidence of premalignant conditions, dysplasia, malignancy or systemic diseases causing burning sensation of mouth, ulceration or reduction in mouth opening like systemic ulceration.
  • 2. Patients suffering from medically compromised conditions like tuberculosis, HIV, renal and hepatic diseases etc.
  • 3. Pregnant and lactating women.
  • 4. Patients with history of intake drugs known to cause fibrosis.

研究者

发起方
Dr Arvind Kumar Kairo

相似试验